High‐dose ifosfamide in relapsed pediatric osteosarcoma: Therapeutic effects and renal toxicity

Abstract

HD-IFX is effective in patients who have failed conventional chemotherapy including IFX (9 g/m(2)). Improved disease-free survival was achieved in 30% of patients. However, renal failure constitutes an important life-threatening complication and its development is unpredictable.